Investors Investors
Investors

SPARK Ventures

www.sparkventures.com

SPARK Ventures is the leading quoted early-stage venture capital company in Europe. It manages over £240m on behalf of major institutional investors, leading UK universities, and three quoted venture capital trusts. SPARK invests in entrepreneurs to create dynamic businesses in the technology, media, telecoms and healthcare & life sciences sectors. As well as capital, it brings a wealth of experience of developing high growth companies from early stage through to IPO or trade sale, adding value to its investments through active support and strategic direction. SPARK Ventures is the lead investor in Haemostatix.

Albion Ventures LLP

 www.albion-ventures.co.uk

Albion   Ventures LLP is a venture capital investor, specialising in VCTs with around £230 million under management. The business of Albion Ventures was formerly known as Close Ventures and was acquired by its management in early 2009 from Close Brothers Group plc. In the fifteen years since the first fund was launched a dividend has been paid by each fund every year, totalling some £103 million, more than any other VCT manager.  Albion Ventures is authorised and regulated by the Financial Services Authority   

 

 Catapult Venture Managers Limited

www.catapult-vm.co.uk

Catapult Venture Managers Limited (Catapult) has £80m of funds under management and specializes in providing equity capital for businesses requiring between £200k and £2m. Catapult invests in all stages of the business lifecycle including early stage, development capital and MBO/MBIs. Catapult invests in most sectors, but has a particular interest in healthcare, medical devices, environmental and support services.

Nesta

www.nesta.org.uk

Nesta is the National Endowment for Science, Technology & the Arts - a unique body with a mission to make the UK more innovative. NESTA invests in early-stage companies, informs and shapes policy, and delivers practical programmes that inspire others to solve the big challenges of the future. NESTA has endowed funds of over £300m.

Lachesis Fund

www.lachesisfund.co.uk

The Lachesis Fund was established in 2002 and has secured £10.25 million to fund seed stage technology investments originating from eight universities across the East Midlands region of the UK. It is managed by Braveheart Ventures Ltd, a subsidiary of Braveheart Investment Group plc (BRH), the AIM-listed investment management group specialising in venture capital investments and investment services.